Xu F, Wang H J, Lin Z M, Yu B
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Dermatology, Peking University First Hospital, Beijing, China.
Clin Exp Dermatol. 2015 Jun;40(4):404-7. doi: 10.1111/ced.12571. Epub 2015 Feb 10.
Costello syndrome (CS; OMIM 218040) is caused by heterozygous germline mutations of HRAS (OMIM 190020).We report on a patient with sporadic CS presenting with characteristic craniofacial dysmorphism, congenital cardiopulmonary disorders, intellectual impairment, and skin abnormalities manifesting as loose redundant skin of the hands and feet, acanthosis nigricans, multiple naevi and hypotrichosis. Using Sanger sequencing for the case-parents trio, we detected a de novo insertion mutation (c.187_207dup) in HRAS, which was predicted to result in duplication of amino acids 63-69 (p.E63_D69dup). This mutation was recently described in a mild case of CS, with hyperactivation of HRAS and disrupted capacity to respond to incoming signals. Our study delineates the detailed clinical features associated with this noncanonical HRAS mutation and further expands the phenotypic spectrum of CS.
科斯特洛综合征(CS;OMIM 218040)由HRAS(OMIM 190020)的杂合种系突变引起。我们报告了一例散发型CS患者,其表现出典型的颅面畸形、先天性心肺疾病、智力障碍以及皮肤异常,表现为手脚皮肤松弛多余、黑棘皮病、多发性痣和毛发稀少。通过对病例-父母三联体进行桑格测序,我们在HRAS中检测到一个新发插入突变(c.187_207dup),预计该突变会导致氨基酸63 - 69重复(p.E63_D69dup)。该突变最近在一例轻度CS病例中被描述,伴有HRAS的过度激活以及对传入信号反应能力的破坏。我们的研究描述了与这种非典型HRAS突变相关的详细临床特征,并进一步扩展了CS的表型谱。